Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HSPB1 | P04792 | 3/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | BCR | P11274 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31190183 | 1.00 | TDP1 (0.59) | TDP1ATMALDH1A1CYP2D6PDE7A | |
| SCHEMBL40024 | 0.83 | TDP1 (0.64) | TDP1ATMALDH1A1PDE7AMAPT | |
| SCHEMBL29449184 | 0.83 | TDP1 (0.64) | TDP1ATMALDH1A1PDE7AMAPT | |
| SCHEMBL29974945 | 0.81 | ALDH1A1 (0.49) | TDP1ATMALDH1A1CYP2D6MAPT | |
| SCHEMBL29745239 | 0.80 | TDP1 (0.72) | TDP1ATMALDH1A1PDE7AHSPB1 | |
| SCHEMBL216553 | 0.80 | TDP1 (0.72) | TDP1ATMALDH1A1PDE7AHSPB1 | |
| SCHEMBL25329112 | 0.79 | ALDH1A1 (0.46) | TDP1ATMALDH1A1CYP2D6MAPT | |
| SCHEMBL29462665 | 0.78 | ATM (0.63) | TDP1ATMALDH1A1PDE7AMAPT | |
| SCHEMBL102780 | 0.78 | ATM (0.69) | TDP1ATMALDH1A1PDE7AMAPT | |
| SCHEMBL29462663 | 0.78 | ATM (0.69) | TDP1ATMALDH1A1PDE7AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118851912-A | Synthesis method of 2-bromo-5-fluoroacetanilide | 浙江江北南海药业有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-117903173-B | Fluoro indeno-thiophene hole transport material, and preparation method and application thereof | 淮阴工学院 | 2024-09-24 | — | — | CN | claimed |
| CN-117903173-A | Fluoro indeno-thiophene hole transport material, and preparation method and application thereof | 淮阴工学院 | 2024-04-19 | — | — | CN | claimed |
| CN-117417867-A | Enterobacter cloacae (Enterobacter cloacae) ZJUT16 and application thereof | 浙江工业大学 | 2024-01-19 | — | — | CN | claimed |
| CN-117343948-A | Recombinant expression plasmid of nitroreductase EcNTR and application thereof | 浙江工业大学 | 2024-01-05 | — | — | CN | claimed |
| CN-116535408-A | Preparation method of carbazole organic electroluminescent host material | 安徽秀朗新材料科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-112110824-B | Method for preparing 2-bromo-5-fluoroaniline | 上海凌凯医药科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-110627655-B | Synthetic method of 2-bromo-5-fluoro-4-nitroaniline and intermediate thereof | 苏州旺山旺水生物医药有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-113072552-A | Beta-carboline GSK3 beta/DYRK 1A dual inhibitor, preparation method thereof and application thereof in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2021-07-06 | — | — | CN | claimed |
| CN-108640842-B | Synthetic method of 2-bromo-5-fluoronitrobenzene | 大连九信精细化工有限公司 | 2021-06-04 | — | — | CN | claimed |
| CN-112110824-A | Method for preparing 2-bromo-5-fluoroaniline | 上海凌凯医药科技有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-110627655-A | Synthetic method and intermediate of 2-bromo-5-fluoro-4-nitroaniline | 苏州旺山旺水生物医药有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-106083621-B | A kind of synthetic method of the chloro- benzophenone of Amiprol pharmaceutical intermediate 2- amino -5- | 成都切斯特科技有限公司 | 2018-12-04 | — | — | CN | claimed |
| CN-108640842-A | A kind of synthetic method of the bromo- 5- fluoronitrobenzenes of 2- | 大连九信精细化工有限公司 | 2018-10-12 | — | — | CN | claimed |
| CN-106083621-A | A kind of synthetic method of Amiprol pharmaceutical intermediate 2 amino 5 chloro benzophenone | 成都切斯特科技有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-105924333-A | Synthesizing method for diphenhydramine pharmaceutical intermediate diphenyl carbinol | 成都卡迪夫科技有限公司 | 2016-09-07 | — | — | CN | claimed |
| CN-102875389-A | Preparation method of 2-bromo-5-fluoroaniline | CHANGZHOU WATSON FINE CHEMICALS CO LTD | 2013-01-16 | — | — | CN | claimed |
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-0119892-B1 | HYDROXYL AMINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS GROWTH FACTORS FOR VEGETABLES AND COMPOSITIONS THEREOF | ROUSSEL-UCLAF (FR) | 1986-08-13 | — | — | EP | disclosed |
| EP-0119892-A1 | Hydroxyl amine derivatives, their preparation, their use as growth factors for vegetables and compositions thereof | ROUSSEL-UCLAF (FR) | 1984-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | CBLB, CBLC, CBL | TDP1 1843/4885ATM 3423/4885ALDH1A1 3286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.